Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubChem Compound

Items: 1 to 20 of 995

1.

Inhibition of VEGFR2 (unknown origin)

Source:
ChEMBL
Protein Target:
Vascular endothelial growth factor receptor 2
AID:
1633238
2.

Inhibition of wild type cKIT T670I mutant in human GIST-5R cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay

Source:
ChEMBL
Protein Target:
Mast/stem cell growth factor receptor Kit
AID:
1629526
3.

Inhibition of wild type cKIT in human GIST-T1 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay

Source:
ChEMBL
Protein Target:
Mast/stem cell growth factor receptor Kit
AID:
1629525
4.
5.
6.
7.
8.

Inhibition of TEL-fused cKIT T670I mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay

Source:
ChEMBL
Protein Target:
Mast/stem cell growth factor receptor Kit
AID:
1629519
9.

Inhibition of TEL-fused cKIT (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay

Source:
ChEMBL
Protein Target:
Mast/stem cell growth factor receptor Kit
AID:
1629518
10.
12.

Binding affinity to non-auto-inhibited form of wild type human N-terminal GST-tagged FLT3 expressed in baculovirus expression

Source:
ChEMBL
Protein Target:
Receptor-type tyrosine-protein kinase FLT3
AID:
1602343
13.

Binding affinity to human FLT3 ITD mutant expressed in baculovirus expression system

Source:
ChEMBL
Protein Target:
Receptor-type tyrosine-protein kinase FLT3
AID:
1602340
14.

Binding affinity to human FLT3 D835H mutant expressed in baculovirus expression system

Source:
ChEMBL
Protein Target:
Receptor-type tyrosine-protein kinase FLT3
AID:
1602339
19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Refine your results

• What's this?

Actions on your results

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center